Tag: Cancer: Rectal
Decline Seen in Patients Undergoing Surgery for Colon, Rectal Cancer in 2020
Patients undergoing surgery in 2020 versus 2019 had more advanced clinical and pathological tumor stage
Surveillance Colonoscopy Rarely IDs Cancer in Older Adults
Yields higher among patients with a prior advanced adenoma but do not vary significantly with age
Follow-Up Colonoscopy Rate Low Within Six Months of Abnormal Stool Test
Quality performance measure that tracks rates of follow-up within six months of abnormal SBT result is feasible, valid, reliable
Racial Disparities Seen for Locally Advanced Rectal Cancer Outcomes
Authors say that outcomes may be multifactorial in nature
Additional Benefit Seen for Colonoscopy Versus Sigmoidoscopy
In recent study, fewer CRC cases and deaths per 100,000 person-years were observed
Fecal Occult Blood Testing Tied to Reduction in Colorectal Cancer Mortality
Findings show 14 percent decreased colorectal cancer mortality over 14 years
Multitarget Fecal Immunochemical Test Increases Detection of Advanced Adenoma
mtFIT-based screening could reduce incidence of colorectal cancer by 21 percent and associated mortality by 18 percent
Overall Decline in Cancer Deaths Expected in Europe in 2024
However, experts predict rise in colorectal cancer deaths in younger adults
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
Robotic Surgery Preferred for Most Colorectal Cancer Surgeries
Advantage not seen for robotic low anterior resection, which has increased risk for serious complications
